/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Validation of the GRACE 3.0 score and redefinition of the risk threshold for early invasive treatment in non-ST-segment elevation acute coronary syndromes: a modelling study from five countries
Event: ESC Congress 2023
Topic: Non-ST-Elevation Myocardial Infarction (NSTEMI)
Session: Risk stratification in acute coronary syndromes (4)
Circulating dipeptidyl peptidase 3 predicts hemodynamic impairment and premature death in acute coronary syndromes: insights from the prospective multicenter SPUM-ACS study
Event: ESC Congress 2023
Topic: Clinical
Session: Young Investigator Awards Session in Clinical Cardiology
Sex inequities in the performance of the GRACE 2.0 score in non-ST-segment elevation acute coronary syndromes: a multinational observational study in contemporary cohorts from four European countries
Event: ESC Congress 2022
Topic: Non-ST-Elevation Myocardial Infarction (NSTEMI)
Session: What defines risk in acute coronary syndromes
Bleeding risk in patients hospitalized for non-ST-segment elevation acute coronary syndromes in Switzerland: performance of the CRUSADE score
Event: ESC Congress 2022
Topic: Non-ST-Elevation Myocardial Infarction (NSTEMI)
Session: What defines risk in acute coronary syndromes
Remnant cholesterol contributes to residual lipid risk after acute coronary syndromes
Event: ESC Congress 2022
Topic: Epidemiology, Prognosis, Outcome
Session: Coronary artery disease - Epidemiology, prognosis, outcome 5
ESC 365 is supported by
